{"id":60098,"date":"2024-02-28T06:33:56","date_gmt":"2024-02-28T06:33:56","guid":{"rendered":"https:\/\/medsname.com\/pivasta\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"pivasta","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/pivasta\/","title":{"rendered":"Pivasta"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Pivasta?<\/h3>\n<p style=\"margin:0;\"><strong>Pivasta<\/strong> este o marc\u0103 a <strong>pitavastatin<\/strong> (4 mg), un <strong>statin\u0103 (inhibitor HMG-CoA reductaz\u0103)<\/strong> utilizat pentru <strong>sc\u0103derea colesterolului LDL (\u201cr\u0103u\u201d) \u0219i reducerea evenimentelor cardiovasculare<\/strong> \u2014 infarct miocardic, accident vascular cerebral \u0219i deces CV \u2014 la persoanele cu colesterol crescut sau boli cardiovasculare stabilite. Statinele au <strong>cea mai puternic\u0103 dovad\u0103 din studii clinice<\/strong> dintre toate clasele de medicamente hipolipemiante: aproximativ 22% reducere a evenimentelor vasculare majore la fiecare sc\u0103dere cu 1 mmol\/L a LDL-C (meta-analiz\u0103 CTT, &gt;170.000 pacien\u021bi). <strong>Intensitate moderat\u0103 p\u00e2n\u0103 la ridicat\u0103<\/strong>. 2 mg \u2248 atorvastatin 10 mg (reducere LDL ~35%). 4 mg \u2248 atorvastatin 20 mg (~45% reducere LDL). Un statin mai nou cu un profil de interac\u021biuni medicamentoase foarte redus (metabolism CYP minimal) \u0219i un efect favorabil asupra HDL-C \u0219i glucozei. Util \u00een special la <strong>pacien\u021bii cu HIV care iau inhibitori de proteaz\u0103<\/strong>, pacien\u021bii post-transplant \u0219i oricine a avut probleme cu statinele cu multe interac\u021biuni. Datele de rezultate (REAL-CAD, J-STARS) sus\u021bin reducerea evenimentelor cardiovasculare similar cu alte statine la reducere echivalent\u0103 a LDL. Efecte secundare principale: dureri musculare (5\u201310%, de obicei u\u0219oare), u\u0219oar\u0103 cre\u0219tere a transaminazelor, semnal mic de diabet de nou\u0103 apari\u021bie la pacien\u021bii cu risc. Rare dar grave: rabdomioliz\u0103, miopatie necrotizant\u0103 imunomediat\u0103. <strong>Evita\u021bi \u00een sarcin\u0103<\/strong> (categoria X). Poate fi luat \u00een orice moment al zilei, cu sau f\u0103r\u0103 m\u00e2ncare.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Pivasta?<\/h2>\n<p>Pivasta este un medicament hipolipemiant oral care con\u021bine <strong>pitavastatin<\/strong> (4 mg), fabricat de Zuventus Healthcare. Furnizat \u00een cutii de 30, 60, 90 sau 180 de comprimate. Marc\u0103 original\u0103: Livalo \/ Livazo (Kowa, 2009 SUA \/ 2011 UE).<\/p>\n<p>pitavastatin apar\u021bine clasei de <strong>statinelor<\/strong> (inhibitori ai HMG-CoA reductazei), cele mai prescrise \u0219i mai bine documentate medicamente hipolipemiante din lume. Statinele sunt incluse \u00een Lista Medicamentelor Esen\u021biale a OMS \u0219i reprezint\u0103 terapia de prim\u0103 linie \u00een aproape toate recomand\u0103rile moderne de preven\u021bie cardiovascular\u0103 (ACC\/AHA, ESC\/EAS, NICE, CCS). <strong>Intensitate moderat\u0103 p\u00e2n\u0103 la ridicat\u0103<\/strong>. 2 mg \u2248 atorvastatin 10 mg (reducere LDL ~35%). 4 mg \u2248 atorvastatin 20 mg (~45% reducere LDL).<\/p>\n<h2 class=\"wp-block-heading\">Pentru ce se utilizeaz\u0103 Pivasta?<\/h2>\n<ul>\n<li><strong>Preven\u021bie primar\u0103<\/strong> a bolii cardiovasculare aterosclerotice (ASCVD) la persoanele cu risc crescut pe 10 ani (de obicei \u2265 7,5\u201310% sau cu multiple factori de risc)<\/li>\n<li><strong>Preven\u021bie secundar\u0103<\/strong> dup\u0103 infarct miocardic, accident vascular cerebral\/AIT, boal\u0103 arterial\u0103 periferic\u0103 simptomatic\u0103 sau revascularizare \u2014 ace\u0219ti pacien\u021bi necesit\u0103 terapie intensiv\u0103 cu statine indiferent de nivelul LDL ini\u021bial<\/li>\n<li><strong>Hipercolesterolemie familial\u0103<\/strong> (heterozigot\u0103 \u0219i, cu terapii adi\u021bionale, homozigot\u0103)<\/li>\n<li><strong>Diabet zaharat de tip 2 cu factori de risc adi\u021bionali<\/strong> \u2014 statina se adaug\u0103 de obicei de la diagnostic<\/li>\n<li><strong>Boal\u0103 renal\u0103 cronic\u0103<\/strong> (BRC) \u2014 majoritatea ghidurilor recomand\u0103 statin\u0103 \u00b1 ezetimib\u0103 \u00een stadiile 3\u20135 de BRC la pacien\u021bii care nu sunt la dializ\u0103<\/li>\n<li>Unele forme de <strong>dislipidemie mixt\u0103<\/strong> (cu LDL \u0219i trigliceride ridicate)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Pivasta?<\/h2>\n<p>pitavastatin este un inhibitor competitiv al <strong>HMG-CoA reductazei<\/strong>, enzima limitant\u0103 de vitez\u0103 \u00een biosinteza colesterolului \u00een ficat. Blocarea acestei enzime are mai multe efecte \u00een lan\u021b:<\/p>\n<ul>\n<li><strong>Reduce colesterolul intracelular<\/strong> \u00een hepatocite<\/li>\n<li><strong>Stimuleaz\u0103 receptorii LDL<\/strong> pe suprafa\u021ba hepatocitelor \u2014 ficatul extrage mai mult LDL din s\u00e2nge<\/li>\n<li><strong>Scade LDL-C plasmatic<\/strong> cu 25\u201360% \u00een func\u021bie de statin\u0103 \u0219i doz\u0103<\/li>\n<li><strong>Scade moderat trigliceridele<\/strong> (10\u201330%) \u0219i cre\u0219te HDL-C (5\u201310%)<\/li>\n<li><strong>Stabilizeaz\u0103 pl\u0103cile aterosclerotice<\/strong> \u2014 efecte pleiotropice asupra inflama\u021biei, func\u021biei endoteliale \u0219i reactivit\u0103\u021bii plachetare (par\u021bial independente de LDL)<\/li>\n<\/ul>\n<p><strong>Farmacocinetic\u0103:<\/strong> Metabolism CYP minim \u2014 \u00een principal glucuronidat de UGT1A3\/2B7. Acest lucru face ca pitavastatinul s\u0103 fie <strong>cu interac\u021biuni reduse<\/strong>, similar cu rosuvastatin. Timp de \u00eenjum\u0103t\u0103\u021bire: ~12 ore. Poate fi luat \u00een orice moment al zilei, cu sau f\u0103r\u0103 m\u00e2ncare.<\/p>\n<p>Efect clinic: Sc\u0103derea LDL-C \u00een 2 s\u0103pt\u0103m\u00e2ni, atinge aproape maximul \u00een 4\u20136 s\u0103pt\u0103m\u00e2ni. Verifica\u021bi un panel lipidic \u0219i ALT la 6\u201312 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eencepere sau titrare.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrare<\/h2>\n<p>\u00cencepe\u021bi cu 1\u20132 mg o dat\u0103 pe zi. Ajusta\u021bi p\u00e2n\u0103 la maximum 4 mg\/zi la intervale de 4 s\u0103pt\u0103m\u00e2ni.<\/p>\n<ul>\n<li>Lua\u021bi cu sau f\u0103r\u0103 m\u00e2ncare.<\/li>\n<li>Dac\u0103 uita\u021bi o doz\u0103 \u2014 lua\u021bi c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi. Omite\u021bi dac\u0103 este aproape de urm\u0103toarea doz\u0103; nu lua\u021bi o doz\u0103 dubl\u0103.<\/li>\n<li><strong>Considera\u021bii etnice:<\/strong> Nu sunt necesare ajust\u0103ri etnice specifice, de\u0219i datele \u00een popula\u021biile non-asiatice sunt mai limitate dec\u00e2t pentru atorvastatin\/rosuvastatin.<\/li>\n<li><strong>Stilul de via\u021b\u0103 este aditiv.<\/strong> Chiar \u0219i la doza maxim\u0103 de statin\u0103, \u00eembun\u0103t\u0103\u021birea alimenta\u021biei (model mediteranean sau DASH), pierderea \u00een greutate \u0219i exerci\u021biile fizice regulate adaug\u0103 o reducere suplimentar\u0103 de 5\u201315% a LDL pe l\u00e2ng\u0103 efectul medicamentului.<\/li>\n<li><strong>Conformitatea este esen\u021bial\u0103.<\/strong> Statinile func\u021bioneaz\u0103 doar c\u00e2t le lua\u021bi; \u00eentreruperea dup\u0103 remisiunea rezultatelor \u201cnormale\u201d ale colesterolului determin\u0103 revenirea LDL la nivelul pre-tratament \u00een c\u00e2teva s\u0103pt\u0103m\u00e2ni, iar riscul de evenimente cardiovasculare urmeaz\u0103 acela\u0219i model.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p>Statinile sunt \u00een general bine tolerate. \u00cen studiile randomizate ample, rata efectelor adverse \u00een exces fa\u021b\u0103 de placebo este mic\u0103.<\/p>\n<p><strong>Frecvente:<\/strong><\/p>\n<ul>\n<li><strong>Simptome musculare (SAMS \u2014 simptome musculare asociate statinelor)<\/strong> \u2014 dureri, rigiditate, sl\u0103biciune u\u0219oar\u0103. Raportate de 5\u201310% dintre utilizatori \u00een datele observa\u021bionale deschise; studiile randomizate (SAMSON, StatinWISE) arat\u0103 c\u0103 majoritatea simptomelor musculare atribuite statinelor nu sunt de fapt cauzate de acestea (efect nocebo). Mialgia cu adev\u0103rat legat\u0103 de statine apare \u0219i de obicei se rezolv\u0103 la \u00eentrerupere; \u00eencerca\u021bi o alt\u0103 statin\u0103 sau o doz\u0103 mai mic\u0103.<\/li>\n<li><strong>Cre\u0219tere u\u0219oar\u0103 a transaminazelor<\/strong> (ALT\/AST p\u00e2n\u0103 la 3\u00d7 ULN) \u2014 de obicei asimptomatice, adesea se rezolv\u0103 f\u0103r\u0103 \u00eentrerupere.<\/li>\n<li>Tulbur\u0103ri gastrointestinale, cefalee, ame\u021beli<\/li>\n<li>Tulbur\u0103ri de somn (mai frecvente cu statinele lipofile precum simvastatina)<\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar importante:<\/strong><\/p>\n<ul>\n<li><strong>Diabet zaharat de tip 2 de nou\u0103 apari\u021bie<\/strong> \u2014 cre\u0219tere absolut\u0103 mic\u0103 (~1 caz suplimentar la fiecare 200 de ani-pacient) la cei cu factori de risc pre-existen\u021bi pentru diabet. Beneficiul cardiovascular dep\u0103\u0219e\u0219te riscul de diabet \u00een toate grupele de risc care justific\u0103 utilizarea unei statine.<\/li>\n<li><strong>Rabdomioliz\u0103<\/strong> \u2014 foarte rar (&lt; 0,1%). Durere muscular\u0103 sever\u0103 + urin\u0103 \u00eenchis\u0103 + CK crescut\u0103 semnificativ. \u00centrerupe\u021bi tratamentul \u0219i c\u0103uta\u021bi ajutor medical.<\/li>\n<li><strong>Miopatie necrotizant\u0103 imunomediat\u0103<\/strong> \u2014 boal\u0103 muscular\u0103 autoimun\u0103 rar\u0103 declan\u0219at\u0103 de expunerea la statine; persist\u0103 dup\u0103 \u00eentrerupere \u0219i necesit\u0103 imunosupresie. Anticorpii anti-HMGCR pozitivi.<\/li>\n<li><strong>Leziune hepatic\u0103 sever\u0103<\/strong> \u2014 foarte rar\u0103.<\/li>\n<li>Neuropatie periferic\u0103 \u2014 rar\u0103<\/li>\n<li>Pl\u00e2ngeri cognitive (ce\u021buire a memoriei) \u2014 raportate dar neconfirmate ca fiind cauzale \u00een studii mari<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<p><strong>Ciclosporin\u0103<\/strong> \u2014 contraindicate (cre\u0219te semnificativ nivelurile de pitavastatin). <strong>Eritromicina<\/strong> \u2014 reduce\u021bi doza de pitavastatin. <strong>Rifampicin\u0103<\/strong> \u2014 reduce nivelurile de pitavastatin. Nu exist\u0103 interac\u021biuni semnificative cu grapefruit sau CYP3A4. Mai sigur dec\u00e2t simvastatin sau atorvastatin atunci c\u00e2nd pacientul ia inhibitori de proteaz\u0103 HIV, multe antifungice sau medicamente care induc CYP3A4.<\/p>\n<h2 class=\"wp-block-heading\">Cine nu ar trebui s\u0103 ia Pivasta?<\/h2>\n<ul>\n<li><strong>Sarcin\u0103<\/strong> (categoria X) \u2014 \u00eentrerupe\u021bi \u00eenainte de concep\u021bie; statinele nu sunt medicamente pentru colesterolul sarcinii<\/li>\n<li><strong>Al\u0103ptare<\/strong> \u2014 evita\u021bi<\/li>\n<li>Boal\u0103 hepatic\u0103 activ\u0103 sau cre\u0219tere persistent\u0103 neexplicat\u0103 a transaminazelor &gt; 3\u00d7 ULN<\/li>\n<li>Hipersensibilitate cunoscut\u0103 la statine<\/li>\n<li>Istoric de miopatie sau rabdomioliz\u0103 indus\u0103 de statine<\/li>\n<li>Insuficien\u021b\u0103 renal\u0103 sever\u0103 \u2014 necesit\u0103 ajustare de doz\u0103 (\u00een special rosuvastatin\u0103<\/li>\n<li>Unele boli hepatice legate de consumul de alcool<\/li>\n<li>Medicamente concomitante strict contraindicate (variaz\u0103 \u00een func\u021bie de statin\u0103 \u2014 consulta\u021bi Interac\u021biuni medicamentoase)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Pivasta sub 25\u00b0C \u00eentr-un loc uscat, \u00een blisterul original. Depozita\u021bi \u00een afara accesului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Este Pivasta acela\u0219i lucru cu pitavastatinul?<\/h3>\n<p>Da \u2014 Pivasta con\u021bine principiul activ pitavastatin. Autorit\u0103\u021bile de reglementare cer bioechivalen\u021b\u0103 cu marca original\u0103 (Livalo \/ Livazo (Kowa, 2009 SUA \/ 2011 UE)), astfel \u00eenc\u00e2t efectul clinic este acela\u0219i la aceea\u0219i doz\u0103.<\/p>\n<h3 class=\"wp-block-heading\">De ce s\u0103 alegi pitavastatinul \u00een loc de atorvastatin sau rosuvastatin?<\/h3>\n<p>Trei situa\u021bii principale favorizeaz\u0103 pitavastatinul: (1) <strong>HIV la pacien\u021bii care iau inhibitori de proteaz\u0103<\/strong> \u2014 pitavastatinul are interac\u021biuni minime cu inhibitorii de proteaz\u0103, spre deosebire de simvastatin (contraindicit) sau atorvastatin (cu doz\u0103 limitat\u0103). (2) <strong>Poli-medica\u021bie<\/strong> pacien\u021bi care iau mai multe medicamente metabolizate de CYP3A4. (3) <strong>Diabet de nou-apari\u021bie indus de statine<\/strong> preocupare \u2014 pitavastatinul are un semnal mai mic dec\u00e2t rosuvastatinul sau atorvastatinul \u00een unele meta-analize. Pentru reducerea intensiv\u0103 de rutin\u0103 a LDL la pacien\u021bi altfel s\u0103n\u0103to\u0219i, rosuvastatinul r\u0103m\u00e2ne de prim\u0103 inten\u021bie.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Pivasta \u2014 diminea\u021ba sau seara?<\/h3>\n<p>Pute\u021bi lua la orice or\u0103 a zilei, cu sau f\u0103r\u0103 m\u00e2ncare.<\/p>\n<h3 class=\"wp-block-heading\">Trebuie s\u0103 iau Pivasta pe via\u021b\u0103?<\/h3>\n<p>\u00cen majoritatea cazurilor, da. Statinele func\u021bioneaz\u0103 doar c\u00e2t le lua\u021bi. Pentru preven\u021bia secundar\u0103 (dup\u0103 infarct, accident vascular cerebral, stentare) sunt practic pe via\u021b\u0103. Pentru preven\u021bia primar\u0103, pot fi uneori \u00eentrerupte dac\u0103 modific\u0103rile de stil de via\u021b\u0103 realizeaz\u0103 o reducere sus\u021binut\u0103 a LDL cu 40\u201350% \u0219i riscul pe 10 ani scade substan\u021bial, dar \u00eentreruperea dup\u0103 ce riscul este controlat duce de obicei la revenirea LDL la nivelul pre-tratament \u00een c\u00e2teva s\u0103pt\u0103m\u00e2ni.<\/p>\n<h3 class=\"wp-block-heading\">Ce spune\u021bi despre statine \u0219i durerile musculare?<\/h3>\n<p>Aproximativ 5\u201310% dintre utilizatorii de statine raporteaz\u0103 dureri musculare, dar studiile SAMSON (2020) \u0219i StatinWISE (2021) \u2014 studii elegante N-of-1 cu crossover statin\u0103\/placebo \u2014 au ar\u0103tat c\u0103 aproximativ 90% din simptomele musculare atribuite statinelor sunt de fapt independente de placebo (apar la fel de des pe placebo). Mialgia real\u0103 legat\u0103 de statine exist\u0103; dac\u0103 este autentic\u0103, trecerea la o alt\u0103 statin\u0103, reducerea dozei sau administrarea \u00een zile alternative o rezolv\u0103 de obicei. M\u0103sura\u021bi CK dac\u0103 este sever\u0103; opri\u021bi imediat \u0219i consulta\u021bi un medic dac\u0103 durerea muscular\u0103 este sever\u0103 cu urin\u0103 \u00eenchis\u0103 (rabdomioliz\u0103).<\/p>\n<h3 class=\"wp-block-heading\">Ar trebui s\u0103 iau CoQ10 \u00eempreun\u0103 cu Pivasta?<\/h3>\n<p>Statinele reduc nivelurile circulante de CoQ10, dar studiile randomizate de suplimentare cu CoQ10 (200 mg\/zi) nu au ar\u0103tat \u00een mod consistent beneficii pentru simptomele musculare legate de statine. Este sigur, dar suplimentarea ieftin\u0103 nu este un substitut pentru investigarea corect\u0103 a durerilor musculare persistente.<\/p>\n<h3 class=\"wp-block-heading\">Pot consuma alcool \u00een timp ce iau Pivasta?<\/h3>\n<p>Consumul moderat de alcool (1\u20132 unit\u0103\u021bi\/zi) este acceptabil. Consumul excesiv cre\u0219te riscul de cre\u0219tere a enzimelor hepatice \u0219i ar trebui evitat. Discuta\u021bi sincer cu clinicianul dvs.; alcoolul este un factor mai important pentru problemele hepatice dec\u00e2t statina.<\/p>\n<h3 class=\"wp-block-heading\">Ce se \u00eent\u00e2mpl\u0103 dac\u0103 uit s\u0103 iau Pivasta?<\/h3>\n<p>Lua\u021bi-l imediat cum v\u0103 aminti\u021bi. Dac\u0103 este aproape de urm\u0103toarea doz\u0103 programat\u0103, omite\u021bi-o \u0219i continua\u021bi conform programului \u2014 nu lua\u021bi o doz\u0103 dubl\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Pivasta online?<\/h3>\n<p>Pute\u021bi comanda Pivasta (4 mg) de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Livr\u0103m \u00een \u00eentreaga lume cu ambalaj discret \u0219i stoc original de la produc\u0103tori certifica\u021bi WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente \u00eenrudite pentru colesterol<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pivasta\/\">Pivasta \u2014 Pitavastatin 4 mg (statin\u0103 f\u0103r\u0103 interac\u021biuni)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ezedoc\/\">Ezedoc \u2014 Ezetimib\u0103 (adaugat la statin\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipicard\/\">Lipicard \u2014 Fenofibrat (sc\u0103dere trigliceride)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-cholesterol-treatments\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru colesterol ridicat<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat. Durere muscular\u0103 sever\u0103 cu urin\u0103 \u00eenchis\u0103 la culoare, g\u0103lbire neexplicat\u0103 a pielii\/ochilor sau sl\u0103biciune brusc\u0103 necesit\u0103 evaluare medical\u0103 urgent\u0103. Statinele sunt categoria X \u00een sarcin\u0103.<\/div>\n<h3 class=\"wp-block-heading\">De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Pivasta este furnizat\u0103 de un produc\u0103tor certificat WHO-GMP cu documenta\u021bie COA complet\u0103. Livr\u0103m \u00een \u00eentreaga lume \u00een ambalaje simple \u0219i discrete, iar fiecare comand\u0103 este acoperit\u0103 de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>. Descrierea tranzac\u021biei la plata cu cardul afi\u0219eaz\u0103 procesatorul de pl\u0103\u021bi reglementat (un procesator de pl\u0103\u021bi cu card reglementat), niciodat\u0103 \u201cMedsBase\u201d sau nume de medicamente.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/nebilong\/\">Nebilong<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glinil-m\/\">Glinil M<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/betapro-sr\/\">Betapro-SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/irovel\/\">Irovel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/anaridex\/\">Anaridex<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Sc\u0103derea nivelului de colesterol<br \/>\n\u2705 Reduce riscul de boli de inim\u0103<br \/>\n\u2705 Previne acumularea de pl\u0103ci<br \/>\n\u2705 Sus\u021binere pentru s\u0103n\u0103tatea cardiovascular\u0103<br \/>\n\u2705 Dozaj o dat\u0103 pe zi<\/p>\n<p>Pivasta con\u021bine Pitavastatin.<\/p>","protected":false},"featured_media":60099,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4803,4804],"class_list":{"0":"post-60098","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-pitavastatin","10":"product_tag-pivasta","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60098"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/60099"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60098"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60098"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60098"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}